Risk factors for VIA positivity and determinants of screening attendances in Dar es Salaam, Tanzania

BMC Public Health

Volumn 12, Issue 1, 2012, Pages

  Kahesa, Crispin ^a,b   Kjaer, Susanne Kruger ^a,c   Ngoma, Twalib ^b   Mwaiselage, Julius ^b   Dartell, Myassa ^a,c   Iftner, Thomas ^b   Rasch, Vibeke ^a,d  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b Ocean Road Cancer Institute ^*  (Germany)

^c INSTITUTE OF CANCER EPIDEMIOLOGY   (Denmark)

^d ODENSE UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Cervical cancer; HIV; HPV; Screening; Tanzania; VIA

Indexed keywords

ADULT; ARTICLE; EARLY DIAGNOSIS; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; METHODOLOGY; MIDDLE AGED; PAPILLOMAVIRUS INFECTION; QUALITATIVE RESEARCH; RISK FACTOR; SEXUAL BEHAVIOR; SOCIOECONOMICS; TANZANIA; UTERINE CERVIX TUMOR; UTILIZATION REVIEW;

ADULT; EARLY DETECTION OF CANCER; FEMALE; HIV INFECTIONS; HUMANS; MIDDLE AGED; PAPILLOMAVIRUS INFECTIONS; QUALITATIVE RESEARCH; RISK FACTORS; SEXUAL BEHAVIOR; SOCIOECONOMIC FACTORS; TANZANIA; UTERINE CERVICAL NEOPLASMS;

MLCS; MLOWN;

EID: 84870480017     PISSN: None     EISSN: 14712458     Source Type: Journal    
DOI: 10.1186/1471-2458-12-1055     Document Type: Article

References (31)

1. Worldwide burden of cervical cancer in 2008. Arbyn M, Castellsague X, de Sanjose S, Bruni L, Saraiya M, Bray F, Ferlay J, Ann Oncol 2011 22 12 2675 2686 10.1093/annonc/mdr015 21471563
2. Effective screening programmes for cervical cancer in low- and middle-income developing countries. Sankaranarayanan R, Budukh AM, Rajkumar R, Bull World Health Organ 2001 79 10 954 962 11693978 (Pubitemid 33027175)
3. CCA, Progress in Cervical Cancer Prevention: The CCA Report Card Cervical Cancer Action 2012 Available from: http://www.cervicalcanceraction.org/pubs/ CCA-reportcard-low-res.pdf
4. CDC, United States Cancer Statistics: 1999-2007 Incidence and Mortality Web-based Report Atlanta: Department of Health and Human Services; Centers for Disease Control and Prevention; National Cancer Institute 2010 23036670
5. Direct visual inspection for cervical cancer screening: an analysis of factors influencing test performance. Denny L, Kuhn L, Pollack A, Wright TC Jr, Cancer 2002 94 6 1699 1707 10.1002/cncr.10381 11920531 (Pubitemid 34241107)
6. Sankaranarayanan R, Wesley RS, A practical manual on visual screening for cervical neoplasia Lyon, France: International Agency for Research on Cancer Technical publication 2003
7. Evaluation of cervical visual inspection screening in Dar es Salaam, Tanzania. Ngoma T, Muwonge R, Mwaiselage J, Kawegere J, Bukori P, Sankaranarayanan R, Int J Gynaecol Obstet 2010 109 2 100 104 10.1016/j.ijgo.2009.11.025 20152973
8. Effectiveness, safety and acceptability of 'see and treat' with cryotherapy by nurses in a cervical screening study in India. Sankaranarayanan R, Rajkumar R, Esmy PO, Fayette JM, Shanthakumary S, Frappart L, Thara S, Cherian J, Br J Cancer 2007 96 5 738 743 10.1038/sj.bjc.6603633 17311015 (Pubitemid 46376636)
9. Association between invasive cancer of the cervix and HIV-1 infection in Tanzania: the need for dual screening. Kahesa C, Mwaiselage J, Wabinga HR, Ngoma T, Kalyango JN, Karamagi CA, BMC Publ Health 2008 8 262 10.1186/1471-2458-8-262
10. UNAIDS, Report on Global Aids Epidermic 2008 Available from: http://www.unaids.org/en/dataanalysis/knowyourepidemic/epidemiologypublications/ 2008reportontheglobalaidsepidemic/
11. National Bureau of Statistics, Tanzania National House Hold Survey Dar es Salaam 2007
12. WHO, omprehesive cervical cancer control: A guide to essential practice Geneva: World Health Organization 2006
13. Evaluation of simple rapid HIV assays and development of national rapid HIV test algorithms in Dar es Salaam, Tanzania. Lyamuya EF, Aboud S, Urassa WK, Sufi J, Mbwana J, Ndugulile F, Massambu C, BMC Infect Dis 2009 9 19 10.1186/1471-2334-9-19 19226452
14. The interrelation of HIV, cervical human papillomavirus, and neoplasia among antenatal clinic attenders in Tanzania. Mayaud P, Gill DK, Weiss HA, Uledi E, Kopwe L, Todd J, Ka-Gina G, Grosskurth H, Hayes RJ, Mabey DC, et al. Sex Transm Infect 2001 77 4 248 254 10.1136/sti.77.4.248 11463923 (Pubitemid 32682138)
15. Assessing the gain in diagnostic performance when two visual inspection methods are combined for cervical cancer prevention. Muwonge R, Walter SD, Wesley RS, Basu P, Shastri SS, Thara S, Mbalawa CG, Sankaranarayanan R, J Med Screen 2007 14 3 144 150 10.1258/096914107782066158 17925087 (Pubitemid 47511124)
16. Determinants of VIA (Visual Inspection of the Cervix After Acetic Acid Application) positivity in cervical cancer screening of women in a peri-urban area in Andhra Pradesh, India. Vedantham H, Silver MI, Kalpana B, Rekha C, Karuna BP, Vidyadhari K, Mrudula S, Ronnett BM, Vijayaraghavan K, Ramakrishna G, et al. Cancer Epidemiol Biomarkers Prev 2010 19 5 1373 1380 10.1158/1055-9965.EPI-09-1282 20447927
17. Screening test accuracy studies: how valid are our conclusions? Application to visual inspection methods for cervical screening. Mahe C, Gaffikin L, Cancer Causes Control 2005 16 6 657 666 10.1007/s10552-005-0296-4 16049804 (Pubitemid 41110956)
18. Natural history of human papillomavirus type 16 virus-like particle antibodies in young women. Ho GY, Studentsov YY, Bierman R, Burk RD, Cancer Epidemiol Biomarkers Prev 2004 13 1 110 116 10.1158/1055-9965.EPI-03-0191 14744741 (Pubitemid 38116628)
19. Risk factors for high-risk human papillomavirus infection and cofactors for high-grade cervical disease in Peru. Almonte M, Ferreccio C, Gonzales M, Delgado JM, Buckley CH, Luciani S, Robles SC, Winkler JL, Tsu VD, Jeronimo J, et al. Int J Gynecol Cancer 2011 21 9 1654 1663 10.1097/IGC.0b013e3182288104 21892094
20. Cervical cancer risk factors and predictors of cervical dysplasia among women in south-west Nigeria. Ogunbowale T, Lawoyin TO, Aust J Rural Health 2008 16 6 338 342 10.1111/j.1440-1584.2008.01013.x 19032205
21. Early age at first sexual intercourse and early pregnancy are risk factors for cervical cancer in developing countries. Louie KS, de Sanjose S, Diaz M, Castellsague X, Herrero R, Meijer CJ, Shah K, Franceschi S, Munoz N, Bosch FX, Br J Cancer 2009 100 7 1191 1197 10.1038/sj.bjc.6604974 19277042
22. Early marriage and HIV risks in sub-Saharan Africa. Clark S, Stud Fam Plann 2004 35 3 149 160 10.1111/j.1728-4465.2004.00019.x 15511059 (Pubitemid 39338346)
23. The social constructions of sexuality: marital infidelity and sexually transmitted disease-HIV risk in a Mexican migrant community. Hirsch JS, Higgins J, Bentley ME, Nathanson CA, Am J Public Health 2002 92 8 1227 1237 10.2105/AJPH.92.8.1227 12144974 (Pubitemid 34815781)
24. Meta-analysis of social inequality and the risk of cervical cancer. Parikh S, Brennan P, Boffetta P, Int J Cancer 2003 105 5 687 691 10.1002/ijc.11141 12740919 (Pubitemid 36687738)
25. Advancing cervical cancer prevention initiatives in resource-constrained settings: insights from the Cervical Cancer Prevention Program in Zambia. Mwanahamuntu MH, Sahasrabuddhe VV, Kapambwe S, Pfaendler KS, Chibwesha C, Mkumba G, Mudenda V, Hicks ML, Vermund SH, Stringer JS, et al. PLoS Med 2011 8 5 1001032 10.1371/journal.pmed.1001032 21610859
26. Association of cervical SIL and HIV-1 infection among Zimbabwean women in an HIV/STI prevention study. Chirenje ZM, Loeb L, Mwale M, Nyamapfeni P, Kamba M, Padian N, Int J STD AIDS 2002 13 11 765 768 10.1258/095646202320753727 12437897 (Pubitemid 35222011)
27. Prevalence and predictors of squamous intraepithelial lesions of the cervix in HIV-infected women in Lusaka, Zambia. Parham GP, Sahasrabuddhe VV, Mwanahamuntu MH, Shepherd BE, Hicks ML, Stringer EM, Vermund SH, Gynecol Oncol 2006 103 3 1017 1022 10.1016/j.ygyno.2006.06.015 16875716 (Pubitemid 44830069)
28. Increased risk of high-grade cervical squamous intraepithelial lesions and invasive cervical cancer among African women with human immunodeficiency virus type 1 and 2 infections. Hawes SE, Critchlow CW, Faye Niang MA, Diouf MB, Diop A, Toure P, Aziz Kasse A, Dembele B, Salif Sow P, Coll-Seck AM, et al. J Infect Dis 2003 188 4 555 563 10.1086/376996 12898443 (Pubitemid 37011808)
29. Human papillomavirus infection in women infected with the human immunodeficiency virus. Sun XW, Kuhn L, Ellerbrock TV, Chiasson MA, Bush TJ, Wright TC Jr, N Engl J Med 1997 337 19 1343 1349 10.1056/NEJM199711063371903 9358128 (Pubitemid 27467768)
30. Prevalence of human papillomavirus in women with invasive cervical carcinoma by HIV status in Kenya and South Africa. Vuyst HD, Ndirangu G, Moodley M, Tenet V, Estambale B, Meijer CJ, Snijders PJ, Clifford G, Franceschi S, Int J Cancer 2011 131 4 949 955 21960453
31. High-risk human papillomavirus reactivation in human immunodeficiency virus-infected women: risk factors for cervical viral shedding. Theiler RN, Farr SL, Karon JM, Paramsothy P, Viscidi R, Duerr A, Cu-Uvin S, Sobel J, Shah K, Klein RS, et al. Obstet Gynecol 2010 115 6 1150 1158 10.1097/AOG. 0b013e3181e00927 20502284